StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report issued on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Shares of SRNE opened at $0.00 on Wednesday. Sorrento Therapeutics has a 1 year low of $0.00 and a 1 year […]
Sorrento Therapeutics (NASDAQ:SRNE) Now Covered by Analysts at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Ninth Circuit Rules That Biopharmaceutical Company's Announcement Of COVID-19 mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.
Ninth Circuit Rules That Biopharmaceutical Company's Announcement Of COVID-19 "Cure" Did Not Violate Securities Laws marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.